Modulation of insulin-like growth factor actions in L6a1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: A dual role for IGFBP-5

Journal of Cellular Physiology

Volumn 177, Issue 1, 1998, Pages 47-57

  Ewton, Daina Z ^a   Coolican, Sharon A ^a   Mohan, Subburaman ^b   Chernausek, Steven D ^c   Florini, James R ^a  

^a SYRACUSE UNIVERSITY   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; HORMONAL REGULATION; HORMONE ACTION; MYOBLAST; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADAPTOR PROTEINS, VESICULAR TRANSPORT; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLAVONOIDS; GENE EXPRESSION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE FIBERS; MYOGENIN; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEINS; PROTO-ONCOGENE PROTEINS C-FOS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TYROSINE;

ANIMALIA;

EID: 0031713316     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199810)177:1<47::AID-JCP5>3.0.CO;2-E     Document Type: Article

References (45)

1. Andress, D.L., and Birnbaum, R.S. (1992) Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J. Biol. Chem., 267:22467-22472.
2. Andress, D.L., Loop, S.M., Zapf, J., and Kiefer, M.C. (1993) Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells. Biochem. Biophys. Res. Commun., 195:25-30.
3. Bach, L.A., and Rechler, M.M. (1995) Insulin-like growth factor binding proteins. Diabetes Rev., 3:38-60.
4. Bach, L.A., Hsieh, S.P., Brown, A.L., and Rechler, M.M. (1994) Recombinant human insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced differentiation of L6A1 myoblasts. Endocrinology, 135:2168-2176.
5. Bach, L.A., Salemi, R., and Leeding, K.S. (1995) Roles of insulin-like growth factor (IGF) receptors and IGF-binding proteins in IGF-II induced proliferation and differentitation of L6A1 rat myoblasts. Endocrinology, 136:5061-5069.
6. Bautista, C.M., Baylink, D.J., and Mohan, S. (1991) Isolation of a novel insulin-like growth factor binding protein from human bone: A potential candidate in fixing IGF-II in human bone. Biochem. Biophys. Res. Commun., 176:756-763.
7. Brown, E.J., Hsiao, D., and Rosenthal, S.M. (1992) Induction and peak gene expression of insulin-like growth factor II follows that of myogenin during differentiation of BC3H-1 muscle cells. Biochem. Biophys. Res. Commun., 183:1084-1089.
8. Cheung, P.T., Smith, E.P., Shimisaki, S., Ling, N., and Chernausek, S.D. (1991) Characterization of an insulin-like growth factor binding protein (IGFBP-4) produced by the B104 neuronal cell line: Chemical and biological properties and differential synthesis by sublines. Endocrinology, 129:1006-1015.
9. Cheung, P.T., Wu, J., Banach, W., and Chernausek, S.D. (1994) Glucocorticoid regulation of an insulin-like growth factor binding protein-4 protease produced by a rat neuronal cell line. Endocrinology, 135:1328-1335.
10. Coolican, S.A., Samuel, D.S., Ewton, D.Z., McWade, F.J., and Florini, J.R. (1997) The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem., 272:6653-6662.
11. Damon, S.E., Haugk, K.L., Birnbaum, R.S., and Quinn, L.S. (1998) Retrovirally mediated overexpression of insulin-like growth factor binding protein 4: Evidence that insulin-like growth factor is required for skeletal muscle differentiation. J. Cell. Physiol., 175:109-120.
12. Engert, J.C., Berglund, E.B., and Rosenthal, N. (1996) Proliferation precedes differentiation in IGF-I-stimulated myogenesis. J. Cell Biol., 135:431-440.
13. Ewton, D.Z., and Florini, J.R. (1981) Effect of somatomedins and insulin on myoblast differentiation in vitro. Dev. Biol., 86:31-39.
14. Ewton, D.Z., and Florini, J.R. (1995) Insulin-like growth factor binding proteins-4, -5, and -6 may play specialized roles during L6 myoblast proliferation and differentiation. J. Endocrinol., 144:539-553.
15. Ewton, D.Z., Falen, S.L., and Florini, J.R. (1987) The type II IGF receptor has low affinity for IGF-I analogs: Pleiotypic actions of IGFs on myoblasts are apparently mediated by the type I receptor. Endocrinology, 120:115-124.
16. Ewton, D.Z., Magri, K.A., and Florini, J.R. (1994a) Roles of IGF-I, IGF-II, and IGFBPs in myogenesis. In: The insulin-like growth factors and their regulatory proteins. R.C. Baxter, P.D. Gluckman, and R. G. Rosenfeld, eds. Excerpta Medica, Amsterdam, pp. 283-290.
17. Ewton, D.Z., Roof, S.L., Magri, K.A., McWade, F.J., and Florini, J.R. (1994b) IGF-II is more active than IGF-I in stimulating L6A1 myogenesis: Greater mitogenic actions of IGF-I delay differentiation. J. Cell. Physiol., 161:277-284.
18. Florini, J.R. (1989) Assay of creatine kinase in microtiter plates using thio-NAD to allow monitoring at 405 nM. Anal. Biochem., 182:399-404.
19. Florini, J.R., Ewton, D.Z., Falen, S.L., and VanWyk, J.J. (1986) Biphasic concentration dependency of the stimulation of myoblast differentiation by somatomedins. Am. J. Physiol. (Cell. Physiol.), 250:771-778.
20. Florini, J., Magri, K., Ewton, D., James, P., Grindstaff, K., and Rotwein, P. (1991a) "Spontaneous" differentiation of skeletal myoblasts is controlled by autocrine secretion of insulin-like growth factor-II. J. Biol. Chem., 266:15917-15923.
21. Florini, J.R., Ewton, D.Z., and Roof, S.L. (1991b) IGF-I stimulates terminal myogenic differentiation by induction of myogenin gene expression. Mol. Endocrinol., 5:718-724.
22. Florini, J.R., Ewton, D.Z., and Coolican, S.A. (1996) Growth hormone and the insulin-like growth factor system in myogenesis. Endocr. Rev., 17:481-517.
23. Giorgetti, S., Pelicci, P.G., Pelicci, G., and Obberghen, E. (1994) Involvement of src-homology/collagen (She) proteins in signaling through the insulin receptor and the insulin-like growth factor-I receptor. Eur. J. Biochem., 223:195-202.
24. Giorgino, F., and Smith, R.J. (1995) Dexamethasone enhances insulin-like growth factor-I effects on skeletal muscle proliferation. Role of specific intracellular signaling pathways. J. Clin. Invest., 96:1473-1483.
25. James, P.L., Stewart, C.E.H., and Rotwein, P. (1996) Insulin-like binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism. J. Cell. Biol., 133:683-693.
26. Jones, J.I., and Clemmons, D.R. (1995) Insulin-like growth factors and their binding proteins: Biological actions. Endocr. Rev., 16:3-34.
27. Kaliman, P., Vinals, F., Testar, X., Palacin, M., and Zorzano, A. (1996) Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J. Biol. Chem., 271:19146-19151.
28. Kaliman, P., Canicio, J., Shepherd, P.R., Beeton, C.A., Testar, X., Palacin, M., and Zorzano, A. (1998) Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: Dominant negative p85 expression blocks differentiation of L6E9 muscle cells. Mol. Endocrinol., 12:66-77.
29. Lamphere, L., and Lienhard, G.E. (1992) Components of signaling pathways for insulin and insulin-like growth factor-I in muscle myoblasts and myotubes. Endocrinology, 131:2186-2202.
30. LeRoith, D., Werner, H., Beitner-Johnson, D., and Roberts, C.T. (1995) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev., 16:143-163.
31. Magri, K.A., Benedict, M.R., Ewton, D.Z., and Florini, J.R. (1994) Negative feedback regulation of IGF-II gene expression in differentiating myoblasts in vitro. Endocrinology, 135:53-62.
32. McCusker, R.H., and Clemmons, D.R. (1994) Effects of cytokines on insulin-like growth factor-binding protein secretion by muscle cells in vitro. Endocrinology, 134:2095-2102.
33. McCusker, R.H., Camacho-Hubner, C., and Clemmons, D.R. (1989) Identification of the types of insulin-like growth factor-binding proteins that are secreted by muscle cells in vitro. J. Biol. Chem., 264:7795-7800.
34. Mohan, S., Nakao, Y., Honda, Y., Landale, E., Leser, U., Dony, C., Lang, K., and Baylink, D.J. (1995) Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J. Biol. Chem., 270:20424-20431.
35. Myers, M.G., Grammer, T.C., Wang, L.-M., Sun, X.J., Pierce, J.H., Blenis, J., and White, M.F. (1994) Insulin receptor substrate-1 mediates phosphatidylinositol 3′-kinase and p70 S6k signaling during insulin, insulin-like growth factor-I, and interleukin-4 stimulation J. Biol. Chem., 269:28783-28789.
36. Ong, J., Yamashita, S., and Melmed, S. (1987) Insulin-like growth factor I induces c-fos messenger ribonucleic acid in L6 skeletal muscle cells. Endocrinology, 120:353-357.
37. Pinset, C., Garcia, A., Rousse, S., Dubois, C., and Montarras, D. (1997) Wortmannin inhibits IGF-dependent differentiation in the mouse myogenic cell line C2. C.R. Acad. Sci., 320:367-374.
38. Rajaram, S., Baylink, D.J., and Mohan, S. (1997) Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulations and functions. Endocr. Rev., 18:801-831.
39. Rosen, K.M., Wentworth, B.M., Rosenthal, N., and Villa-Komaroff, L. (1993) Specific, temporally regulated expression of the insulin-like growth factor II gene during muscle cell differentiation. Endocrinology, 133:474-481.
40. Rosenthal, S.M., and Cheng, Z.-Q. (1995) Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts. Proc. Natl. Acad. Sci. USA, 92:10307-10311.
41. Silverman, L., Cheng, Z.-Q., Hsiao, D., and Rosenthal., S.M. (1995) Skeletal muscle cell-derived insulin-like growth factor (IGF) binding proteins inhibit IGF-induced myogenesis in rat L6E9 cells. Endocrinology, 136:720-726.
42. Stewart, C.E.H., and Rotwein, P. (1996) Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts J. Biol. Chem., 271:11330-11338.
43. Stewart, C.E.H., James, P.L., Fant, M.E., and Rotwein, P. (1996) Overexpression of insulin-like growth factor-II induces accelerated myoblast differentiation. J. Cell. Physiol., 169:23-32.
44. Tollefsen, S.E., Lajara, R., McCusker, R.H., Clemmons, D.R., and Rotwein, P. (1989a) Insulin-like growth factors (IGF) in muscle development. Expression of IGF-I, the IGF-I receptor, and an IGF binding protein during myoblast differentiation. J. Biol. Chem., 264:13810-13817.
45. Tollefsen, S.E., Sadow, J.L., and Rotwein, P. (1989b) Coordinate expression of insulin-like growth factor II and its receptor during muscle differentiation. Proc. Natl. Acad. Sci. USA, 86:1543-1547.